Imaging-based modalities compared for identifying at-risk MASH
FibroScan-aspartate aminotransferase (FAST) demonstrated the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis (MASH), according to a study published in the October issue of the American Journal of Gastroenterology.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Genomic cancer driver study reveals new clues to why some prostate cancers become aggressive
United Kingdom
-
Menopause hormone therapy gets stronger endorsement from OB-GYNs in expanded guideline
United Kingdom
-
Strong food preferences may help explain why changing eating habits is hard
United Kingdom
-
Molecular imaging demonstrates promise for predicting complete pathologic response in HER2-positive breast cancer
United Kingdom
-
Fueling growth, blinding immunity: The two-way amino acid trap inside tumors
United Kingdom
-
Persistent gaps remain in hearing aid coverage, especially for older and lower-income adults, study finds
United Kingdom
-
Spatial map of the lung reveals cellular mechanisms driving damage and fibrosis in severe COVID-19
United Kingdom
-
Study finds common chemicals may alter normal breast development
United Kingdom